[Federal Register Volume 72, Number 96 (Friday, May 18, 2007)]
[Notices]
[Pages 28074-28075]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: E7-9639]


-----------------------------------------------------------------------

DEPARTMENT OF JUSTICE

Drug Enforcement Administration


Manufacturer of Controlled Substances; Notice of Registration

    By Notice dated December 14, 2006, and published in the Federal 
Register on December 22, 2006, (71 FR 77065-77066), Johnson Matthey 
Inc., Custom Pharmaceuticals Department, 2003 Nolte Drive, West 
Deptford, New Jersey 08066, made application by letter to the Drug 
Enforcement Administration (DEA) to be registered as a bulk 
manufacturer of 14-Hydroxymorphinone (9654), a basic class of 
controlled substance listed in schedule II.
    The company plans to manufacture the listed controlled substances 
in bulk as an intermediate for use in the production of another 
controlled substance.

[[Page 28075]]

    No comments or objections have been received. DEA has considered 
the factors in 21 U.S.C. 823(a) and determined that the registration of 
Johnson Matthey Inc. to manufacture the listed basic class of 
controlled substance is consistent with the public interest at this 
time. DEA has investigated Johnson Matthey Inc. to ensure that the 
company's registration is consistent with the public interest. The 
investigation has included inspection and testing of the company's 
physical security systems, verification of the company's compliance 
with State and local laws, and a review of the company's background and 
history. Therefore, pursuant to 21 U.S.C. 823, and in accordance with 
21 CFR 1301.33, the above named company is granted registration as a 
bulk manufacturer of the basic class of controlled substance listed.

    Dated: May 9, 2007.
Joseph T. Rannazzisi,
Deputy Assistant Administrator, Office of Diversion Control, Drug 
Enforcement Administration.
[FR Doc. E7-9639 Filed 5-17-07; 8:45 am]
BILLING CODE 4410-09-P